Related Experiment Video

Updated: May 25, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Role of Cochrane reviews in pediatric neurology

Wolfgang Girisch1, Christiane Willhelm, Sven Gottschling

  • 1Medical School, University of Saarland, Homburg, Germany.

Pediatric Neurology
|January 24, 2012
PubMed

Insights

Evidence-based medicine in pediatric neurology requires more high-quality research. Many Cochrane reviews lacked sufficient pediatric data, leading to inconclusive findings and limiting the best quality of care.

Area of Science:

  • Neurology
  • Evidence-Based Medicine
  • Pediatric Care

Background:

  • Evidence-based medicine is crucial for optimal pediatric neurology care.
  • Cochrane reviews are a key source of evidence for medical interventions.
  • Previous reviews have varied in their conclusions regarding treatment efficacy.

Purpose of the Study:

  • To evaluate the quality and findings of Cochrane reviews in pediatric neurology from 1996-2010.
  • To identify limitations in existing research and guide future study design.
  • To assess the proportion of conclusive versus inconclusive evidence in pediatric neurology.

Main Methods:

  • A comprehensive literature review of Cochrane reviews published between 1996 and 2010.
  • Inclusion criteria focused on reviews relevant to pediatric neurology.
  • Categorization of reviews based on recommendations (positive, conditional, negative, no difference, inconclusive).

Main Results:

  • 112 reviews were analyzed; only 17 exclusively focused on pediatric populations.
  • A significant proportion of reviews (33/112) provided clear recommendations, while 30 were inconclusive.
  • Common criticisms included heterogeneous populations, small sample sizes, and lack of study comparability.

Conclusions:

  • There is a persistent need for high-quality research in pediatric neurology.
  • Inconclusive findings increased over time, highlighting methodological challenges.
  • Future randomized controlled trials should prioritize pediatric-specific populations to improve evidence quality.

More Related Videos

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...